Drug Discovery Market Discussed in New Occams Business Research & Consulting Report Recently Published at MarketPublishers.com

08 Dec 2015 • by Natalie Aster

LONDON – Currently, the largest share in the global market for drug discovery belongs to companies from North America. The USA is a home of the most prominent providers of drug discovery technologies and services. Presence of production facilities as well as research laboratories is a key force driving this marketplace.

In Europe, favorable environment provided by the EU drives local research laboratories and institutes.

In the meantime, companies from India, China and Japan are engaged in provision of contract research services to top Western pharma companies.

China is the number one Asian player since a large number of international pharma companies build their plants in the country.

Topical research study “Drug Discovery Market by Country, Company Profiles, Share, Trends, Analysis, Size, Opportunities, Segmentation and Forecast 2015 – 2021” developed by Occams Business Research & Consulting offers an up-close look at the drug discovery marketplace. The report contains a 360-degree overview of the global marketplace. It includes a value chain analysis and discloses key buying criteria. The study unveils unit shipment trends and focuses on the drug discovery pipeline process. The research report explores drivers and restraints of the marketplace and limelights market opps and challenges. It canvasses performance of different market segments and sheds light on regional as well as country markets. Company profiles and market forecast are contained in the research study, too.

Report Details:

Drug Discovery Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Size, Opportunities, Segmentation and Forecast 2015 – 2021
Published: October, 2015
Pages: 140
Price: US$ 4,000.00

More new reports by this publisher are available at Occams Business Research & Consulting page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970